These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6650125)

  • 21. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of oxcarbazepine in the dog.
    Schicht S; Wigger D; Frey HH
    J Vet Pharmacol Ther; 1996 Feb; 19(1):27-31. PubMed ID: 8992022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy.
    Striano S; Striano P; Di Nocera P; Italiano D; Fasiello C; Ruosi P; Bilo L; Pisani F
    Epilepsy Res; 2006 May; 69(2):170-6. PubMed ID: 16515857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients.
    May TW; Rambeck B; Sälke-Kellermann A
    Acta Neurol Scand; 1996 Jun; 93(6):393-7. PubMed ID: 8836299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
    Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.
    Rambeck B; Jürgens UH; May TW; Pannek HW; Behne F; Ebner A; Gorji A; Straub H; Speckmann EJ; Pohlmann-Eden B; Löscher W
    Epilepsia; 2006 Apr; 47(4):681-94. PubMed ID: 16650134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects.
    Volosov A; Xiaodong S; Perucca E; Yagen B; Sintov A; Bialer M
    Clin Pharmacol Ther; 1999 Dec; 66(6):547-53. PubMed ID: 10613609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man.
    Malátková P; Havlíková L; Wsól V
    Chem Biol Interact; 2014 Sep; 220():241-7. PubMed ID: 25063510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gas chromatographic assay for oxcarbazepine and its main metabolites in plasma.
    von Unruh GE; Paar WD
    J Chromatogr; 1985 Nov; 345(1):67-76. PubMed ID: 4086590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta.
    Pienimäki P; Lampela E; Hakkola J; Arvela P; Raunio H; Vähäkangas K
    Epilepsia; 1997 Mar; 38(3):309-16. PubMed ID: 9070593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic drug interactions in children taking oxcarbazepine.
    Sallas WM; Milosavljev S; D'souza J; Hossain M
    Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactivity assessment of carbamazepine-10,11-epoxide, oxcarbazepine, and 10-hydroxy-carbazepine in two automated carbamazepine immunoassays: PETINIA and EMIT 2000.
    Parant F; Bossu H; Gagnieu MC; Lardet G; Moulsma M
    Ther Drug Monit; 2003 Feb; 25(1):41-5. PubMed ID: 12548143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serum.
    Paxton JW; Donald RA
    Clin Pharmacol Ther; 1980 Nov; 28(5):695-702. PubMed ID: 7438687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.
    Antunes Nde J; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre Junior V; Takayanagui OM; Tozatto E; Marques MP; Lanchote VL
    Eur J Clin Pharmacol; 2016 Feb; 72(2):195-201. PubMed ID: 26514967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between carbamazepine concentrations in plasma and saliva in man as determined by liquid chromatography.
    Westenberg HG; de Zeeuw RA; van de Kleijn E; Oei TT
    Clin Chim Acta; 1977 Aug; 79(1):155-61. PubMed ID: 890949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does oxcarbazepine warrant therapeutic drug monitoring? A critical review.
    Bring P; Ensom MH
    Clin Pharmacokinet; 2008; 47(12):767-78. PubMed ID: 19026033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplacental passage of oxcarbazepine and its metabolites in vivo.
    Myllynen P; Pienimäki P; Jouppila P; Vähäkangas K
    Epilepsia; 2001 Nov; 42(11):1482-5. PubMed ID: 11879354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine.
    van Heiningen PN; Eve MD; Oosterhuis B; Jonkman JH; de Bruin H; Hulsman JA; Richens A; Jensen PK
    Clin Pharmacol Ther; 1991 Oct; 50(4):410-9. PubMed ID: 1914377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.